ENTA
Price
$10.65
Change
+$0.28 (+2.70%)
Updated
Nov 4 closing price
Capitalization
310.19M
12 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$35.03
Change
+$4.39 (+14.33%)
Updated
Nov 4 closing price
Capitalization
2.6B
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENTA vs XNCR

ENTA vs XNCR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ENTA vs. XNCR commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Buy and XNCR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ENTA with price predictions
Nov 03, 2026

ENTA in +4.64% Uptrend, advancing for three consecutive days on October 27, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ENTA advanced for three days, in 208 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

ENTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ENTA as a result. In 69 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

The Moving Average Convergence Divergence Histogram (MACD) for ENTA turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 45 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

ENTA moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for ENTA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.069) is normal, around the industry mean (3.051). P/E Ratio (-4.401) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.550) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (5.285) is also within normal values, averaging (439.647).

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. ENTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for XNCR with price predictions
Nov 04, 2026

XNCR in upward trend: price rose above 50-day moving average on October 26, 2026

XNCR moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on XNCR as a result. In 49 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for XNCR just turned positive on October 21, 2026. Looking at past instances where XNCR's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.

The 10-day moving average for XNCR crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Following a +18.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where XNCR advanced for three days, in 188 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XNCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

XNCR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XNCR entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.176) is normal, around the industry mean (2.904). P/E Ratio (-16.218) is within average values for comparable stocks, (-0.738). Projected Growth (PEG Ratio) (0.740) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (16.949) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. XNCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XNCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
ENTA vs XNCR: Fundamental Ratings
ENTA
XNCR
OUTLOOK RATING
1..100
1443
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
7634
P/E GROWTH RATING
1..100
2296
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XNCR's Valuation (17) in the Biotechnology industry is somewhat better than the same rating for ENTA (59). This means that XNCR’s stock grew somewhat faster than ENTA’s over the last 12 months.

XNCR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ENTA (100). This means that XNCR’s stock grew similarly to ENTA’s over the last 12 months.

XNCR's SMR Rating (97) in the Biotechnology industry is in the same range as ENTA (98). This means that XNCR’s stock grew similarly to ENTA’s over the last 12 months.

XNCR's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for ENTA (76). This means that XNCR’s stock grew somewhat faster than ENTA’s over the last 12 months.

ENTA's P/E Growth Rating (22) in the Biotechnology industry is significantly better than the same rating for XNCR (96). This means that ENTA’s stock grew significantly faster than XNCR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTAXNCR
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 22 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 05, 2026
Stock price -- (ENTA: $10.37 vs. XNCR: $35.03)
Brand notoriety: ENTA and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 80% vs. XNCR: 154%
Market capitalization -- ENTA: $310.19M vs. XNCR: $2.6B
ENTA [@Biotechnology] is valued at $310.19M. XNCR’s [@Biotechnology] market capitalization is $2.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $139.16B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green while XNCR’s FA Score has 1 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than ENTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 3 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • ENTA’s TA Score: 3 bullish, 5 bearish.
  • XNCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than ENTA.

Price Growth

ENTA (@Biotechnology) experienced а -14.86% price change this week, while XNCR (@Biotechnology) price change was +16.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.31%. For the same industry, the average monthly price growth was -10.93%, and the average quarterly price growth was -16.13%.

Reported Earning Dates

ENTA is expected to report earnings on Nov 16, 2026.

XNCR is expected to report earnings on Feb 24, 2027.

Industries' Descriptions

@Biotechnology (-3.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with VIR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
-0.58%
VIR - ENTA
46%
Loosely correlated
+2.00%
ASMB - ENTA
43%
Loosely correlated
+2.10%
XNCR - ENTA
43%
Loosely correlated
+3.30%
ZYME - ENTA
43%
Loosely correlated
+3.93%
EDIT - ENTA
42%
Loosely correlated
+1.17%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDVG51.811.06
+2.09%
T. Rowe Price Dividend Growth ETF (TDVG)
ADME55.980.56
+1.01%
Aptus Drawdown Managed Equity ETF (ADME)
DDTL22.570.22
+1.01%
Innovator Equity Dual Directional 10 Buffer ETF - July (DDTL)
KDRN22.48N/A
N/A
Kingsbarn Tactical Bond ETF (KDRN)
WISE30.12-0.21
-0.69%
Themes Generative Artificial Intelligence ETF (WISE)